Skip to main content

Stage 1B Process Scale-Up Considerations

  • Chapter
  • First Online:
Solid Oral Dose Process Validation

Abstract

Processes ready for commercialization post Stage 1A need to demonstrate capability for commercial scaling. Commercial scale-up studies are conducted as part of Stage 1B process design activities. The manufacturing process is evaluated to estimate effect of scale. Product control strategy is optimized post Stage 1B studies. The successful completion of the stage ensures readiness for process performance qualification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sayeed-Desta N, Pazhayattil AB, Collins J, Doshi C. A science and risk based pragmatic methodology for blend and content uniformity assessment. AAPS PharmSciTech. 2018;19(3):1483–92.

    CAS  PubMed  Google Scholar 

  2. SAS. Statistics for FDA process validation using JMP software, SAS. 2018.

    Google Scholar 

  3. Nayak BK, Elchidana P, Dixit M, Sahu PK. QbD approach: tablet compression process optimization using design of experiments. Int J Pharm Sci. 2016;38(2):45–53.

    CAS  Google Scholar 

  4. Pazhayattil A, Sayeed-Desta N, Iyer V. ICH Q12 post approval change management protocol: advantages for consumers, Regulators and Industry, RAPS. 2017.

    Google Scholar 

  5. US FDA. Guidance for Industry: Immediate release: solid oral dosage forms scale-up and post approval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation, CDER, CMC. 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 American Association of Pharmaceutical Scientists

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pazhayattil, A.B., Sayeed-Desta, N., Fredro-Kumbaradzi, E., Collins, J. (2018). Stage 1B Process Scale-Up Considerations. In: Solid Oral Dose Process Validation. AAPS Introductions in the Pharmaceutical Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-02472-7_5

Download citation

Publish with us

Policies and ethics